“Use of cannabidiol for the control of refractory symptoms in convulsive syndromes and neurodegenerative diseases”, Alerta (San Salvador), vol. 6, no. 1, pp. 78–85, Jan. 2023, doi: 10.5377/alerta.v6i1.15563.